Abiopharma

🔍 Ericksen Scott D (Executive)

Company: ILLUMINA, INC. (ILMN)

Report Date: 2026-03-05

Detailed Transactions and Holdings:

• Acquired 3,217 shares of Common Stock at $128.24 per share (Direct)
  Date: 2026-03-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 16,446.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 1,609 shares of Performance Shares (Derivative)
  Date: 2026-03-05 | Code: A | Expires: 2028-12-31 | equity_swap_involved: 0 | shares_owned_after: 1,609.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 1,609 shares of Performance Shares (Derivative)
  Date: 2026-03-05 | Code: A | Expires: 2028-12-31 | equity_swap_involved: 0 | shares_owned_after: 1,609.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: Grant of restricted stock units shall vest as follows: 25% of the shares subject to the award shall vest on each of February 15, 2027, February 15, 2028, February 15, 2029, and February 15, 2030, subject to awardee's continuing status as a service provider on such dates.
• F2: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028 with vesting on December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the Company's actual three-year average consolidated non-GAAP earnings per share growth for fiscal years 2026-2028, relative to pre-defined objectives, subject to awardee's continuing to be a service provider on such dates.
• F3: Each performance stock unit represents a contingent right to receive one share of common stock based on the Company's relative total shareholder return for the fiscal year ending December 31, 2028. The number of shares issued will range from 0% to 250% of the amount specified above, based on the company's relative total shareholder return for the fiscal year ending December 31, 2028, relative to pre-defined objectives, subject to the awardee's continuing status as a service provider on such dates.